- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00436462
Expression of Steroid Receptors in Endometrium
November 6, 2009 updated by: Aristotle University Of Thessaloniki
Expression of Steroid Receptors in Endometrium During the Early Follicular Phase in Stimulated Cycles
Expression of steroid receptors in endometrium during ovarian stimulation.
Study Overview
Status
Completed
Conditions
Detailed Description
The purpose of this study is to examine in stimulated cycles a) whether there is a difference in expression of steroid receptors in stroma and glands of endometrium between different days during the follicular phase b)whether there are secretory changes detected by endometrium histology before ovulation c)whether there is an association between expression of steroid receptors in endometrium and exposure to oestradiol and progesterone during the follicular phase.
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Thessaloniki, Greece, 56429
- Unit of Human Reproduction, 1st Department of Obstetrics & Gynecology, AUTH, Papageorgiou Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 39 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
infertile women
Description
Inclusion Criteria:
- Treatment by IUI,
- BMI:18-29KGR/M2,
- No previous ovarian surgery,
- Normal hysterosalpingography,
- Estradiol < 80pg/ml and progesterone < 1.6ng/ml on day 2 of the cycle
Exclusion Criteria:
- Endometriosis,
- Severe male factor
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Steroid receptors expression in endometrium during early follicular phase
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
In which day:day o+2, day 0+4 or day HCG
Time Frame: 1 month
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Basil C Tarlatzis, MD,PhD, Unit of Human Reproduction, 1st Department of Obst & Gyn, Aristotle University of Thessaloniki, Papageorgiou Hospital, Greece
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, Devroey P. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002 Nov;78(5):1025-9. doi: 10.1016/s0015-0282(02)03323-x.
- Papanikolaou EG, Bourgain C, Kolibianakis E, Tournaye H, Devroey P. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. Hum Reprod. 2005 Jun;20(6):1541-7. doi: 10.1093/humrep/deh793. Epub 2005 Feb 10.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2005
Primary Completion (Actual)
December 1, 2007
Study Completion (Actual)
December 1, 2007
Study Registration Dates
First Submitted
February 16, 2007
First Submitted That Met QC Criteria
February 16, 2007
First Posted (Estimate)
February 19, 2007
Study Record Updates
Last Update Posted (Estimate)
November 9, 2009
Last Update Submitted That Met QC Criteria
November 6, 2009
Last Verified
November 1, 2009
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UHR-4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometrium
-
Sun Yat-sen UniversityUnknown
-
Fertigo Medical LtdKaplan Medical CenterCompleted
-
Ibn Sina HospitalGanna HospitalCompleted
-
Kaohsiung Veterans General Hospital.UnknownEndometrium | LaserTaiwan
-
Peking Union Medical College HospitalMerck Serono International SACompletedPostmenopausal EndometriumChina
-
Heilongjiang University of Chinese MedicineCompletedEndometrium; SenilityChina
-
Nanjing UniversityUnknown
-
Philipps University Marburg Medical CenterGerman Cancer AidRecruitingCancer of Endometrium Stage I | Cancer of Endometrium Stage IIJapan, Germany, Korea, Republic of
-
Cukurova UniversityCompleted
-
Eli Lilly and CompanyGynecologic Oncology GroupCompletedNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Uterine Neoplasms | Genital Neoplasms, Female | Endometrial Neoplasms | Endometrial Cancer | Endometrium Cancer | Cancer of Endometrium | Cancer of the Endometrium | Neoplasms, EndometrialUnited States